Full-Time

Clinical Biospecimen Operations Manager

Posted on 4/15/2025

Natera

Natera

1,001-5,000 employees

Biotechnology firm specializing in genetic testing

Compensation Overview

$111.9k - $139.9k/yr

Senior

Company Historically Provides H1B Sponsorship

Remote in USA

Candidates must be based in the United States.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • BA/BS degree in life sciences, related field, or equivalent
  • Minimum of 5 years of experience working on clinical studies in the academic, biopharma, diagnostics, or medical device fields
  • Familiarity with biospecimen management, sample processing, and biobanking best practices
  • Experience with clinical EDC systems
  • Familiarity with the organization and structure of the Trial Master File (TMF)
  • Competency in SOPs, ICH-GCP, FDA Regulations
  • Proficiency in MS Word, Excel and PowerPoint
  • Demonstrated ability to work independently
  • Outgoing and confident demeanor
  • Demonstrated analytical skills and ability to identify problems and propose solutions
  • Detail oriented, with solid organization and time management skills
Responsibilities
  • Maintain oversight of all study sample operational activities including planning, coordinating and tracking clinical trial sample testing to ensure results are provided within agreed upon TAT
  • Work with Data Management to develop and maintain dashboards and KPIs representing metrics and trends related clinical trial sample testing and the status of clinical studies and present to study teams and management teams, as needed
  • Meticulously track clinical trial samples from sample receipt to result reporting to investigator sites and/or external collaborators (and sample return, if applicable)
  • Utilize operational and project management skills to anticipate, investigate and resolve issues to ensure deliverables and TAT are met; raise issues to Pharma Operations Team Leader
  • Responsible for handling data files to support timely result reporting
  • Review and provide input to clinical study protocol for sample collection requirements and alignment with the SOW, study plans and company policies
  • Oversee clinical trial supplies related to biospecimen collection, processing, shipment, and storage as, well as maintenance of associated tracking information
  • Organize and plan meetings and provide agenda and meeting minutes as needed
  • Assist in developing study plans (e.g. Communication Plan) and departmental and study specific SOPs and work instructions with SME
  • Assist in the preparation, handling, filing, and archiving of clinical documentation and reports according to SOPs and study requirements; set up and maintain study files in eTMF
  • Monitor studies to identify protocol deviations or data discrepancies and issue data clarification forms, as needed
  • Partner with other research and development groups at Natera to achieve deliverables

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera also offers tests for family planning and prenatal screening, including the Panorama NIPT, which has conducted over 2 million tests. The company generates revenue through testing kits and services, often reimbursed by insurance, and provides genetic counseling for personalized patient support.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI adoption in genetic testing enhances Natera's prenatal and cancer diagnostics.
  • Remote healthcare trends expand the market for Natera's at-home genetic testing kits.
  • Advancements in liquid biopsy technologies benefit Natera's market reach and accessibility.

What critics are saying

  • Increased competition from companies like Lantheus Holdings may impact Natera's market share.
  • The sale of company stock by Natera's CFO might indicate potential internal concerns.
  • Adoption challenges for the Donor Quantity Score in Prospera Heart could affect its success.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for prenatal and cancer diagnostics.
  • The company offers unique tests like Signatera and Prospera Heart with Donor Quantity Score.
  • Natera provides remote genetic counseling, enhancing accessibility for patients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

5%
Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.

Simply Wall St
Mar 13th, 2025
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Last week, Natera (NasdaqGS:NTRA) announced a strategic expansion of its Board of Directors with the appointment of Monica Bertagnolli.

Investing.com
Mar 10th, 2025
Natera launches HEROES trial for breast cancer treatment

Natera launches HEROES trial for breast cancer treatment.

Financial Modeling Prep
Feb 28th, 2025
Lantheus Holdings, Inc. (NASDAQ:LNTH) Demonstrates Strong Capital Efficiency

Lantheus competes with other companies in the medical and pharmaceutical industries, such as ShockWave Medical, Medpace Holdings, LivaNova, Apellis Pharmaceuticals, and Natera.